Regional Cerebral Glucose Metabolic Abnormalities in Bipolar II Depression

Biological Psychiatry

Volumn 61, Issue 6, 2007, Pages 765-775

  Mah, Linda ^a   Zarate Jr , Carlos A ^a   Singh, Jaskaran ^a   Duan, Yu Fei ^a   Luckenbaugh, David A ^a   Manji, Husseini K ^a   Drevets, Wayne C ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

amygdala; bipolar disorder; Cerebral metabolism; depression; mood stabilizers; prefrontal cortex; striatum

Indexed keywords

FLUORODEOXYGLUCOSE F 18; LITHIUM; VALPROATE SEMISODIUM;

ADULT; AMYGDALOID NUCLEUS; ARTICLE; BIPOLAR II DISORDER; CINGULATE GYRUS; CLINICAL ARTICLE; CONTROLLED STUDY; DISORDERS OF CARBOHYDRATE METABOLISM; FEMALE; GLUCOSE BRAIN LEVEL; HUMAN; INSULA; MALE; NUCLEUS ACCUMBENS; ORBITAL CORTEX; POSITRON EMISSION TOMOGRAPHY; POST HOC ANALYSIS; PRIORITY JOURNAL; PUTAMEN; SUBICULUM;

AMYGDALA; ANTIMANIC AGENTS; BIPOLAR DISORDER; BLOOD GLUCOSE; BRAIN; BRAIN MAPPING; DEPRESSION; FEMALE; HUMANS; LITHIUM COMPOUNDS; MALE; NUCLEUS ACCUMBENS; POSITRON-EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PUTAMEN; REFERENCE VALUES; VALPROIC ACID;

EID: 33847268162     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2006.06.009     Document Type: Article

References (45)

1. Bauer M., London E.D., Rasgon N., Berman S.M., Frye M.A., Altshuler L.L., et al. Supraphysiological doses of levothyroxine alter regional cerebral metabolism and improve mood in bipolar depression. Mol Psychiatry 10 (2005) 456-469
2. Baxter Jr. L.R., Schwartz J.M., Phelps M.E., Mazziotta J.C., Guze B.H., Selin C.E., et al. Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch Gen Psychiatry 46 (1989) 243-250
3. Breiter H.C., Gollub R.L., Weisskoff R.M., Kennedy D.N., Makris N., Berke J.D., et al. Acute effects of cocaine on human brain activity and emotion. Neuron 19 (1997) 591-611
4. Brooks R.A. Alternative formula for glucose utilization using labeled deoxyglucose. J Nucl Med 23 (1982) 538-539
5. Calabrese J.R., Hirschfeld R.M., Reed M., Davies M.A., Frye M.A., Keck P.E., et al. Impact of bipolar disorder on a U.S. community sample. J Clin Psychiatry 64 (2003) 425-432
6. Cohen R.M., Gross M., Nordahl T.E., Semple W.E., Oren D.A., and Rosenthal N. Preliminary data on the metabolic brain pattern of patients with winter seasonal affective disorder. Arch Gen Psychiatry 49 (1992) 545-552
7. Drevets W.C. Neuroimaging studies of mood disorders. Biol Psychiatry 48 (2000) 813-829
8. Drevets W.C. Brain structural abnormalities in mood disorders. In: Zorumski C.F., and Rubin E.H. (Eds). Psychopathology in the Genome and Neuroscience Era (2005), American Psychiatric Publishing Inc, Washington, DC 119-152
9. Drevets W.C., Gadde K., and Krishnan R. Neuroimaging studies of depression. In: Charney D.S., Nestler E.J., and Bunney B.J. (Eds). The Neurobiological Foundation of Mental Illness, 2nd ed. (2004), Oxford University Press, New York 461-490
10. Drevets W.C., Gautier C., Price J.C., Kupfer D.J., Kinahan P.E., Grace A.A., et al. Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria. Biol Psychiatry 49 (2001) 81-96
11. Drevets W.C., Price J.L., Bardgett M.E., Reich T., Todd R.D., and Raichle M.E. Glucose metabolism in the amygdala in depression: Relationship to diagnostic subtype and plasma cortisol levels. Pharmacol Biochem Behav 71 (2002) 431-447
12. Drevets W.C., Price J.L., Simpson Jr. J.R., Todd R.D., Reich T., Vannier M., et al. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 386 (1997) 824-827
13. Drevets W.C., Price J.L., Videen T.O., Todd R.D., Reich T., and Vannier M.E. Metabolic abnormalities in the subgenual prefrontal cortex and ventral striatum in mood disorders. Astr Soc Neurosci 21 (1995) 260
14. Drevets W.C., Spitznagel E., and Raichle M.E. Functional anatomical differences between major depressive subtypes. J Cereb Blood Flow Metab 15 (1995) S93
15. Drevets W.C., Videen T.O., Price J.L., Preskorn S.H., Carmichael S.T., and Raichle M.E. A functional anatomical study of unipolar depression. J Neurosci 12 (1992) 3628-3641
16. Du J., Gray N.A., Falke C., Yuan P., Szabo S., and Manji H.K. Structurally dissimilar antimanic agents modulate synaptic plasticity by regulating AMPA glutamate receptor subunit GluR1 synaptic expression. Ann N Y Acad Sci 1003 (2003) 378-380
17. Duvernoy H. The Human Brain, 2nd ed (1999), Springer-Verlag Wien, New York
18. Friston K.J., Worsley K.J., Frackowiak R.S.J., Mazziotta J.C., and Evans A.C. Assessing the significance of focal activations using their spatial extent. Hum Brain Mapp 1 (1994) 214-220
19. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 32 (1959) 50-55
20. Hirayasu Y., Shenton M.E., Salisbury D.F., Kwon J.S., Wible C.G., Fischer I.A., et al. Subgenual cingulate cortex volume in first-episode psychosis. Am J Psychiatry 156 (1999) 1091-1093
21. Judd L.L., Schettler P.J., Akiskal H.S., Maser J., Coryell W., Solomon D., et al. Long-term symptomatic status of bipolar I vs. bipolar II disorders. Int J Neuropsychopharmacol 6 (2003) 127-137
22. Kessler R.C., Chiu W.T., Demler O., Merikangas K.R., and Walters E.E. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62 (2005) 617-627
23. Ketter T., and Drevets W.C. Neuroimaging studies of bipolar depression: Functional neuropathology, treatment effects, and predictors of clinical response. Clin Neurosci Res 2 (2002) 182-192
24. Ketter T.A., Kimbrell T.A., George M.S., Dunn R.T., Speer A.M., Benson B.E., et al. Effects of mood and subtype on cerebral glucose metabolism in treatment-resistant bipolar disorder. Biol Psychiatry 49 (2001) 97-109
25. Kimbrell T.A., Ketter T.A., George M.S., Little J.T., Benson B.E., Willis M.W., et al. Regional cerebral glucose utilization in patients with a range of severities of unipolar depression. Biol Psychiatry 51 (2002) 237-252
26. Lucey J.V., Costa D.C., Busatto G., Pilowsky L.S., Marks I.M., Ell P.J., et al. Caudate regional cerebral blood flow in obsessive-compulsive disorder, panic disorder and healthy controls on single photon emission computerised tomography. Psychiatry Res 74 (1997) 25-33
27. MacFall J.R., Payne M.E., Provenzale J.E., and Krishnan K.R. Medial orbital frontal lesions in late-onset depression. Biol Psychiatry 49 (2001) 803-806
28. Montgomery S.A., and Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 134 (1979) 382-389
29. Moore D.F., Altarescu G., Barker W.C., Patronas N.J., Herscovitch P., and Schiffmann R. White matter lesions in Fabry disease occur in 'prior' selectively hypometabolic and hyperperfused brain regions. Brain Res Bull 62 (2003) 231-240
30. Neumeister A., Nugent A.C., Waldeck T., Geraci M., Schwarz M., Bonne O., et al. Neural and behavioral responses to tryptophan depletion in unmedicated patients with remitted major depressive disorder and controls. Arch Gen Psychiatry 61 (2004) 765-773
31. Nugent A.C., Milham M.P., Bain E.E., Mah L., Cannon D.M., Marrett S., et al. Cortical abnormalities in bipolar disorder investigated with MRI and voxel-based morphometry. Neuroimage 30 2 (2006) 485-497
32. Ongur D., Drevets W.C., and Price J.L. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci U S A 95 (1998) 13290-13295
33. Ongur D., Ferry A.T., and Price J.L. Architectonic subdivision of the human orbital and medial prefrontal cortex. J Comp Neurol 460 (2003) 425-449
34. Osuch E.A., Ketter T.A., Kimbrell T.A., George M.S., Benson B.E., Willis M.W., et al. Regional cerebral metabolism associated with anxiety symptoms in affective disorder patients. Biol Psychiatry 48 (2000) 1020-1023
35. Poline J.B., Worsley K.J., Evans A.C., and Friston K.J. Combining spatial extent and peak intensity to test for activations in functional imaging. Neuroimage 5 (1997) 83-96
36. Rajkowska G., Miguel-Hidalgo J.J., Wei J., Dilley G., Pittman S.D., Meltzer H.Y., et al. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol Psychiatry 45 (1999) 1085-1098
37. Robinson R.G., Boston J.D., Starkstein S.E., and Price T.R. Comparison of mania and depression after brain injury: Causal factors. Am J Psychiatry 145 (1988) 172-178
38. Rosenthal R. Meta-Analytic Procedures for Social Research, Revised Edition (1991), Sage Publications, Newbury Park, CA
39. Shulman R.G., Rothman D.L., Behar K.L., and Hyder F. Energetic basis of brain activity: Implications for neuroimaging. Trends Neurosci 27 (2004) 489-495
40. Szeszko P.R., Robinson D., Alvir J.M., Bilder R.M., Lencz T., Ashtari M., et al. Orbital frontal and amygdala volume reductions in obsessive-compulsive disorder. Arch Gen Psychiatry 56 (1999) 913-919
41. Szeszko P.R., Strous R.D., Goldman R.S., Ashtari M., Knuth K.H., Lieberman J.A., et al. Neuropsychological correlates of hippocampal volumes in patients experiencing a first episode of schizophrenia. Am J Psychiatry 159 (2002) 217-226
42. Tabachnick B.G., and Fidell L.S. Using Multivariate Statistics (1989), Harper & Row, New York
43. Talairach J., and Tournoux P. Co-Planar Stereotaxic Atlas of the Human Brain (1988), Thieme Medical Publishers Inc, New York
44. Vidal-González I, Vidal-González B, Rauch SL, Quirk GJ (in review): Microstimulation reveals opposing influences of prelimbic and infralimbic cortex on the expression of conditioned fear.
45. Woods R.P., Mazziotta J.C., and Cherry S.R. MRI-PET registration with automated algorithm. J Comput Assist Tomogr 17 (1993) 536-546